Botulinum neurotoxin type B - A rapid wrinkle reducer

Seminars in Cutaneous Medicine and Surgery

Volumn 22, Issue 2, 2003, Pages 131-135

  Jacob, Carolyn I ^a  

^a Adv Skin and Mohs Surgery Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BOTULINUM TOXIN A; BOTULINUM TOXIN B; SODIUM CHLORIDE;

DRUG DOSE REGIMEN; DRUG EFFICACY; ESTHETICS; EYE IRRITATION; HEADACHE; HUMAN; HYPERHIDROSIS; REJUVENATION; REVIEW; SIDE EFFECT; SKIN DEFECT; SKIN REJUVENATION; TREATMENT INDICATION; TREATMENT OUTCOME; WRINKLE; XEROSTOMIA;

EID: 0038160946     PISSN: 10855629     EISSN: None     Source Type: Journal    
DOI: 10.1053/sder.2003.50009     Document Type: Review

References (17)

1. Carruthers JDA, Carruthers JA. Treatment of glabellar frown lines with Botulinum A exotoxin. J Dermatol Surg Oncol 18:17-21, 1992
2. Simpson LL: The origin, structure, and pharmacological activity of botulinum toxin. Pharmacol Rev 33:155-188, 1981
3. Brin MF, Lew MF, Adler CH, et al: Safety and efficacy of neurobloc (botulinum toxin type B) in type A-resistant cervical dystonia. Neurology 53:1431-1438, 1999
4. Das Gupta BR: The structure of botulinum neurotoxin, in Simpson LL, (ed): Botulinum neurotoxins and tetanus toxin. New York: NY, Academic Press, 1989, pp 53-67
5. Coffield JA, Considine RV, Simpson LL: The site and mechanism of action of botulinum neurotoxin, in Jankovic J, Hallett M (d): Therapy With Botulinum Toxin. New York, NY, Marcel Dekker, Inc, 1994, pp 3-13
6. Callaway JE, Arezzo JC, Crethlein AJ: Botulinum toxin type B: An overview of its biochemistry and preclinical pharmacology. Semin Cutan Med Surg 20:127-136, 2001
7. Myobloc Package Insert. San Diego, CA, Elan Pharmaceuticals, 2000.
8. Setler P: The biochemistry of botulinum toxin type B. Neurology 55:S22-28, 2000 (suppl 5)
9. Alam M, Dover JS, Arndt KA: Pain associated with injection of botulinum A exotoxin reconstituted using isotonic sodium chloride with and without preservative. Arch Derm 138: 510-514, 2002
10. Jacob CI: Botulinum Toxin B - Onset, duration, and efficacy: Comparing dilution with preserved versus non-preserved saline. Cosmetic Dermatol 2003 (in press)
11. Sadick NS: Botulinum Toxin Type B for glabellar wrinkles: A prospective open-label response study. Dermatol Surg 28:817-821, 2002
12. Spencer J Goldberg DJ, Gordon M: Botulinum B treatment of the glabellar and frontalis regions: a dose response analysis. J Cosmet Laser Ther 4:19-23, 2002
13. Matarasso SL: Comparison of botulinum toxin types A and B: A bilateral, double-blind evaluation in the treatment of canthal rhytides. Dermatol Surg 29:7-13, 2003
14. Dressler D, Benecke R: Autonomic side effects of botulinum toxin type B treatment of cervical dystonia and hyperhidrosis. Eur Neurol 49:34-38, 2003
15. Arezzo JC, Litwak MS, Meyer KE, et al: The duration of paralysis of the trapezius muscle induced by botulinum toxins in the cynomolgus monkey. ASDS Poster presentation, Nov 2002. Chicago, IL)
16. Lowe NJ, Yamauchi PS, Lask GP, et al: Botulinum toxins types A and B for brow furrows: Preliminary experiences with type B toxin dosing. J Cosmet Laser Ther 4:15-18, 2002
17. Sadick N: A Dose Related Study of Myobloc Botulinum Toxin B in the Treatment of Hyperkinetic Facial Wrinkles, ASDS meeting presentation, Nov 2002, Chicago, IL